Evoq Remedies
₹11.35
+0.25 (2.25%)
23 April, 2024 13:54 BSE: 543500
NSE: EVOQISIN: INE0JVD01011
Start SIP in Evoq Remedies
Start SIPEvoq Remedies Performance
Day Range
- Low 0
- High 0
52 Week Range
- Low 0
- High 0
- Open Price0
- Previous Close0
- Volume
Evoq Remedies Financials
Indicator | Mar 2023 |
---|---|
Total Revenue Annual Cr | 26 |
Operating Expenses Annual Cr | 24 |
Operating Profit Annual in Cr | -4 |
Depreciation Cr | 0 |
Interest Annual Cr | 0 |
Tax Annual Cr | 1 |
Net Profit Annual Cr | 2 |
Evoq Remedies Technicals
EMA & SMA
Current Price
₹11.35
+0.25 (2.25%)
- Bullish Moving Average
- ___
- 9
- Bearish Moving Average
- ___
- 7
- 20 Day
- ₹10.83
- 50 Day
- ₹11.46
- 100 Day
- ₹12.21
- 200 Day
- ₹12.98
- 20 Day
- ₹10.52
- 50 Day
- ₹11.68
- 100 Day
- ₹12.46
- 200 Day
- ₹13.31
Evoq Remedies Resistance and Support
PIVOT
₹10.92
Resistance | |
---|---|
First Resistance | 11.28 |
Second Resistance | 11.47 |
Third Resistance | 11.83 |
RSI | 51.56 |
MFI | 77.91 |
MACD Single Line | -0.24 |
MACD | -0.14 |
Support | |
---|---|
First Resistance | 10.73 |
Second Resistance | 10.37 |
Third Resistance | 10.18 |
Evoq Remedies Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 44,000 | 3,600,080 | 81.82 |
Week | 22,000 | 1,800,040 | 81.82 |
1 Month | 73,647 | 5,670,824 | 77 |
6 Month | 331,633 | 18,077,333 | 54.51 |
Evoq Remedies Result Highlights
Evoq Remedies Synopsis
BSE-Medical-Ethical Drugs
Evoq Remedies belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 20.39 Cr. and Equity Capital is Rs. 13.60 Cr. for the Year ended 31/03/2023. Evoq Remedies Ltd. is a Public Limited Listed company incorporated on 24/02/2010 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ2010PLC059692 and registration number is 059692.Market Cap | 15 |
Sales | 20 |
Shares in Float | 0.35 |
No of funds | |
Yield |
Book Value | 0.61 |
U/D Vol ratio | 1 |
LTDebt / Equity | |
Alpha | -0.19 |
Beta | 1.17 |
Evoq Remedies
Owner Name | Mar-24 | Sep-23 |
---|---|---|
Promoters | 20.53% | 73.53% |
Individual Investors | 73.38% | 24.91% |
Others | 6.09% | 1.56% |
Evoq Remedies Management
Name | Designation |
---|---|
Mr. Bhumishth Narendrabhai Patel | Chairman & Managing Director |
Mr. Pranav Manoj Vajani | Independent Director |
Mr. Digesh Mansukhlal Deshaval | Independent Director |
Mr. Narendrakumar Patel | Non Executive Director |
Evoq Remedies Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Evoq Remedies Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-01-22 | Preferential issue of shares | |
2023-11-10 | Half Yearly Results | (Revised) |
2023-05-25 | Audited Results | |
2022-11-07 | Half Yearly Results & Rights issue | |
2022-05-30 | Audited Results |
Evoq Remedies FAQs
What is Share Price of Evoq Remedies ?
Evoq Remedies share price is ₹11 As on 23 April, 2024 | 13:40
What is the Market Cap of Evoq Remedies ?
The Market Cap of Evoq Remedies is ₹15.4 Cr As on 23 April, 2024 | 13:40
What is the P/E ratio of Evoq Remedies ?
The P/E ratio of Evoq Remedies is As on 23 April, 2024 | 13:40
What is the PB ratio of Evoq Remedies ?
The PB ratio of Evoq Remedies is 0.6 As on 23 April, 2024 | 13:40